T. Rowe Price discloses 5.9% stake in PROCEPT

T. Rowe Price Investment Management, Inc. reports beneficial ownership of 3,271,408 shares of PROCEPT BioRobotics Corp common stock, representing 5.9% of the outstanding class as of the reported date.

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. reports beneficial ownership of 3,271,408 shares of PROCEPT BioRobotics Corp common stock, representing 5.9% of the outstanding class as of the reported date. T. Rowe Price has sole voting and dispositive power over all these shares.

The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of PROCEPT. It also expressly denies being the beneficial owner of the securities beyond what is required for this disclosure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does T. Rowe Price hold in PROCEPT BioRobotics (PRCT)?

T. Rowe Price Investment Management, Inc. reports beneficial ownership of 3,271,408 PROCEPT BioRobotics common shares, representing 5.9% of the class. This gives the firm a significant institutional position while remaining below typical 10% insider thresholds.

Does T. Rowe Price control PROCEPT BioRobotics (PRCT) through this ownership?

T. Rowe Price states the shares were acquired and are held in the ordinary course of business, not to change or influence control. The firm certifies it is not participating in any control-related transactions, and it expressly denies beneficial ownership beyond this disclosure.

How much voting power does T. Rowe Price have in PROCEPT BioRobotics (PRCT)?

T. Rowe Price reports sole voting power over 3,271,408 PROCEPT BioRobotics common shares. It has no shared voting power, indicating that decisions on how these shares are voted rest solely with T. Rowe Price Investment Management, Inc.

What type of investor is T. Rowe Price in relation to PROCEPT BioRobotics (PRCT)?

T. Rowe Price Investment Management, Inc. files as an institutional investor, including as an investment adviser under SEC rules. It indicates the holdings are managed professionally, consistent with a typical asset management role rather than an activist or control-seeking investor.

Does T. Rowe Price share dispositive power over PROCEPT BioRobotics (PRCT) shares?

No. T. Rowe Price reports sole dispositive power over all 3,271,408 PROCEPT BioRobotics common shares. It indicates it alone decides when and how these shares are sold or otherwise disposed of, with no shared authority reported.

Why is T. Rowe Price’s 5.9% holding in PROCEPT BioRobotics (PRCT) disclosed?

The 5.9% stake exceeds the 5% ownership threshold that triggers beneficial ownership reporting. When an institutional investor crosses this level, it must publicly disclose its position, voting power, and intentions regarding control, as T. Rowe Price has done here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 10:28 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PROCEPT BIOROBOTICS CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

74276L105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 74276L105

1

Names of Reporting Persons

T. Rowe Price Investment Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,271,408.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,271,408.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,271,408.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PROCEPT BIOROBOTICS CORP
(b)	Address of issuer's principal executive offices: 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
Item 2.
(a)	Name of person filing: T. Rowe Price Investment Management, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 74276L105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3271408
(b)	Percent of class: 5.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3271408
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3271408
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Investment Management, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	02/17/2026